John H Noseworthy

Author PubWeight™ 13.47^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Not every patient with multiple sclerosis should be treated at time of diagnosis.	Arch Neurol	2006	2.67
2	Citation and readership metrics: how does Neurology measure up?	Neurology	2008	2.61
3	Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.	Arch Neurol	2004	2.37
4	Multiple sclerosis.	Annu Rev Med	2002	1.80
5	Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.	Mult Scler	2012	1.01
6	Randomized controlled trials to assess therapies for multiple sclerosis.	Neurology	2002	0.81
7	The Mayo Clinic Value Creation System.	Am J Med Qual	2011	0.81
8	Natalizumab.	Nat Rev Drug Discov	2005	0.80
9	How much can we learn from long-term extension trials in multiple sclerosis?	Neurology	2006	0.75
10	MRI findings in benign multiple sclerosis are variable.	J Neurol	2006	0.75
11	Translating research into treatments.	Neurology	2008	0.75
12	Three tough acts to follow.	Neurology	2011	0.75
13	MRI findings of rapidly progressive ophthalmoplegia and blindness in mucormycosis.	Neurology	2006	0.75
14	Progress report and a farewell.	Neurology	2009	0.75